SEATTLE, Sept. 10 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY)
announced today that Robert Kirkman, M.D., President and Chief Executive
Officer, will present at the 16th Annual BioCentury NewsMakers in the Biotech
Industry Conference on Sept. 16, 2009 in New York.
Dr. Kirkman will present at 3 p.m. Eastern Time. A live and archived
webcast of the presentation will be accessible by visiting the Oncothyreon
website www.oncothyreon.com under the "News & Events" section.
The NewsMakers Conference is designed to stimulate interest in a select
group of public biotech companies and is recognized as a key venue for
reaching financial professionals including financial institutions,
pharmaceutical business development groups, and high net worth investors
active in the sector.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
